Status:
UNKNOWN
UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)
Lead Sponsor:
University Hospital, Angers
Conditions:
Non Alcoholic Fatty Liver Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess UDFF performance (compared to MRI)
Eligibility Criteria
Inclusion
- All patients who had hepatic ultrasound with available UDFF measurements and hepatic MRI (with steatosis quantification sequences) between 01/01/2022 and 31/09/2023 may be included.
Exclusion
- chronic liver disease with a different etiology other than NAFL/NASH or mixed (hepatitis B or C, hemochromatosis, autoimmune hepatitis, Wilson's disease, cholestasic disease, alpha 1 antitrypsin deficiency),
- decompensated cirrhosis (ascites, jaundice, encephalopathy, rupture of esophageal varices),
- hepatocellular carcinoma.
- opposition to the use of its data
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06080386
Start Date
March 1 2022
End Date
October 15 2023
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Angers university hospital
Angers, France, 49000